FDA approves one-dose Johnson & Johnson vaccine

The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.

The FDA said Johnson & Johnson’s vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85 percent protective against the most severe COVID-19 illness.

“The more vaccines that have high efficacy that we can get into play, the better,” Dr. Anthony Fauci, the top U.S. infectious disease expert, said ahead of the FDA’s ruling.

Anthony Fauci